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0929-6441/ª 2014, Elsevier Taiwan LLBackground: If a patient has inflammatory bowel disease (IBD) and enthesitis, he/she can be
classified as having peripheral spondyloarthritis according to criteria set by the Assessment
of Spondyloarthritis International Society. In Taiwan, IBD patients visiting outpatient clinics
can present without joint symptoms, so the prevalence of these musculoskeletal manifesta-
tions may be underestimated. We conducted this study to evaluate enthesitis by ultrasonogra-
phy (US) in IBD patients, and compared these data with healthy controls (HCs).
Materials and methods: Fourteen IBD patients and 14 HCs underwent independent clinical and
ultrasonographic examination of both legs at five entheseal sites. The Glasgow Ultrasound En-
thesitis Scoring System (GUESS) was used to assess the degree of enthesitis in the two groups.
The total score of enthesitis was calculated on the basis of US findings. All US examinations
were undertaken by an experienced rheumatologist blinded to clinical and laboratory
findings.
Results: Two hundred and eighty entheses in 14 patients and 14 HCs were examined by US,
which revealed 42/140 (30%) and 21/140 (15%) abnormal entheseal sites in patients and con-
trols, respectively. The GUESS score was significantly higher in IBD patients than in HCs
(p < 0.05). No significant correlation was noted between the US score of enthesitis and serum
level of C-reactive protein.ivision of Allergy, Immunology, and Rheumatology, Department of Internal Medicine, National Taiwan
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Higher GUESS Score in Inflammatory Bowel Disease 195Conclusion: These data suggest that US is more sensitive than radiography and clinical assess-
ment for the detection of entheseal abnormalities.
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Inflammatory bowel disease (IBD) is a chronic inflammatory
disease of the gastrointestinal tract. There are two main
types of IBD: Crohn’s disease (CD) and ulcerative colitis
(UC). CD and UC have been found to have distinct patho-
logical and clinical characteristics, but their pathogenesis
remains poorly understood. UC is a chronic condition
characterized by relapsing and remitting episodes of
inflammation limited to the mucosal layer of the colon. CD
is characterized by transmural inflammation and skip
lesions.
The incidence of IBD has been reported to change ac-
cording to geographic differences and over time [1,2].
Multiple studies have evaluated the epidemiology of IBD in
various geographic regions. In one of the largest studies in
the USA, based on 9 million health-insurance claims, the
incidence of UC and CD in adults was found to be 238 per
100,000 and 201 per 100,000 population, respectively [3].
Age-standardized incidence rates for IBD, UC, and CD were
found to be 3.14 per 100,000, 2.05 per 100,000, and 1.09
per 100,000 persons, respectively, in a developed region of
Guangdong province, China [4]. The incidence of IBD in
China is similar to that reported for Japan and Hong Kong,
but lower than that in South Korea and Western countries
[4]. The incidence of IBD in Taiwan is 5.6 per 100,000 per-
sons according to the National Health Insurance Research
Database [5].
The presentations of IBD are not confined to the bowel.
Extraintestinal manifestations are observed frequently,
including arthritis, eye involvement, skin disorders, and
pulmonary involvement. However, arthritis is the most
common extraintestinal manifestation, and its prevalence
is 7e16% [6]. Enthesitis is a sign of joint involvement. It
manifests as pain and swelling at the site of attachment of
the tendon to the bone, and the lower limbs are involved
more frequently. Enthesitis is assessed clinically by eliciting
pain at the entheseal site, but this test is neither sensitive
nor specific. Thus, more sensitive studies, such as ultraso-
nography (US) and magnetic resonance imaging, are often
used. However, the use of magnetic resonance imaging is
limited by its cost, accessibility, and lack of simultaneous
evaluation of multiple sites. If a patient has IBD and
enthesitis, he/she can be classified as having peripheral
spondyloarthritis (SpA) according to criteria set by the
Assessment of Spondyloarthritis International Society. The
assessment and treatment of these patients may be
different if they are classified as having peripheral SpA.
Enthesitis is a well-documented phenomenon in IBD pa-
tients. The prevalence of enthesitis of patients with IBD has
been reported to be 5e10% [7,8]. In Taiwan, patients with
IBD presenting to the outpatient departments seldom
complain of joint symptoms. Thus, these musculoskeletal
manifestations could be ignored or their prevalenceunderestimated by history-taking and clinical assessment
alone.
Several methods have been introduced to evaluate the
degree of enthesitis. Balint et al [9] have proposed that US
is useful to evaluate enthesitis, and have recommended it
as a more sensitive method to detect subclinical enthes-
opathy. Further studies have also demonstrated good intra-
and inter-observer reliability and correlation with radio-
logical changes [10e14]. Data on the reference values of
normal individuals in Taiwan are lacking. Hence, we sought
to evaluate enthesitis in patients with IBD using US, and to
collect native ultrasonographic data on entheses in a
normal population in Taiwan.
Materials and methods
Ethics approval of the study protocol
Written informed consent was obtained from each patient
prior to inclusion in the study. The study protocol was
approved by the Research Ethics Committee of the National
Taiwan University Hospital (Taipei, Taiwan).
Study design
This was a prospective study blinded to the US operator and
the physician assessing the patient.
Patients
Eighteen patients referred from the Gastrointestinal Clinic
with a definite diagnosis of IBD (11 UC and 7 CD) were
enrolled [15]. Four patients were excluded because they
declined the US examination for personal reasons.
The study was conducted on 14 patients with IBD (8 UC
and 6 CD) and 14 healthy volunteers recruited from March
2012 to February 2013. Exclusion criteria were: age <20
years; body mass index (BMI) >30 kg/m2; history of severe
trauma to the enthesis, surgery of the knee and/or ankle,
or chronic forms of arthritis (e.g., rheumatoid, gouty, or
psoriatic arthritis).
US assessment
We used a portable US machine (LOGIQ e; GE Healthcare,
Piscataway, NJ, USA) equipped with multi-frequency linear
array transducers (5e13 MHz). B-mode ultrasonography and
power Doppler ultrasonography (PDUS) were used. PDUS
settings were standardized with a pulse-repetition fre-
quency of 500 Hz and a color mode frequency of
9.1e11.1 MHz. PD was considered positive within the
tendon 2 mm proximal to the bony insertion and not at the
body of the tendon [9]. We undertook ultrasonographic
Table 1 Clinical data and GUESS score in patients and
controls.
Patients
(n Z 14)
Controls
(n Z 14)
p
Sex (M:F) 12:2 12:2 1.0
Median age (range) 32.5 (22e61) 30.2 (22e51) 0.21
Height (cm) 169.1  7.0 169.4  10.9 0.33
Weight (kg) 60  9.8 58.4  7.0 1.00
BMI (kg/m2) 20.91  2.8 20.31  1.3 0.60
Disease duration (mo) 33.3  32.9 NA
Oral ulcer 2 0 0.481
Skin rash 0 0 NA
Uveitis history 0 0 NA
CRP (mg/dL) 0.39  0.4 NA
Hb (g/dL) 14  2.1 NA
Sacroiliitis 4 NA
GUESS score 3.43  2.13 1.71  1.53 0.03
Soft-tissue score 3.21  2.04 1.71  1.53 0.04
Bone score 0.21  0.57 0 0.15
Prednisolone use 1 0 1.0
NSAID use 0 0 NA
Anti-TNF-a inhibitor
use
1 0 1.0
Mesalazine/
sulfasalazine
13/1 0 0
Data are presented as n or mean  SD, unless otherwise indi-
cated.
BMIZ body mass index; CRPZ C-reactive protein; FZ female;
GUESS Z Glasgow Ultrasound Enthesitis Scoring System;
Hb Z hemoglobin; M Z male; NA Z not applicable;
NSAID Z nonsteroidal anti-inflammatory drug; SD Z standard
deviation; TNF Z tumor necrosis factor.
196 Y.-F. Hsiao et al.examination of both legs at five entheseal sites: the supe-
rior pole and inferior poles of the patella, tibial tuberosity,
Achilles tendon, and plantar aponeurosis. Multiplanar US
examinations of the superior pole (insertion of the quadri-
ceps tendon), inferior pole of the patella (origin of the
patellar ligament), and the insertion of the patellar liga-
ment at the tibial tuberosity were done by placing the
patient in the supine position with the knee flexed at 30.
The Achilles tendons and proximal plantar aponeurosis
were examined with the patient lying in the prone position
with the feet hanging over the edge of the examination
table with the ankle flexed at 90. We used the Glasgow
Ultrasound Enthesitis Scoring System (GUESS) to assess the
degree of enthesitis in the two groups [9]. The total score
of enthesitis was calculated according to US findings. All US
examinations were carried out by an experienced rheu-
matologist blinded to clinical and laboratory findings.
Clinical and laboratory evaluations
An experienced rheumatologist assessed the joints for
tenderness and swelling. He was blinded to the results of
the US examination. Laboratory tests comprised measure-
ments of serum levels of hemoglobin and C-reactive protein
(CRP); both of which served as parameters reflecting IBD
severity.
Statistical analyses
Statistical analyses were carried out using SPSS version 12.0
(SPSS Inc., Chicago, IL, USA). Quantitative variables are the
mean and range. Categorical variables are the absolute
frequency and percentages. Comparison between inde-
pendent means was done using the ManneWhitney U test.
Relationships between categorical variables were evalu-
ated by Fisher’s exact test. A p value <0.05 was considered
significant.
Results
Complete clinical and US data were obtained for 14 pa-
tients (8 UC and 6 CD) and 14 controls. A total of 280
entheses in 14 patients and 14 HCs were evaluated using
US. Data were collected on the following parameters: age,
sex, weight, height, BMI, disease duration, oral ulcers, skin
rash, uveitis, CRP level, hemoglobin level, sacroiliitis (by
radiography), medication use, and US data.
The mean age was 32.5 years among patients and
30.2 years among controls (pZ 0.22). The mean duration of
IBD was 33.2 months. The mean BMI of patients and controls
was 20.91 kg/m2 and 20.31 kg/m2, respectively. There was
no significant difference between the patients and controls
with respect to age, sex, and BMI. Two patients had a his-
tory of oral ulcers (14.3%) and none had a history of skin
rash or uveitis.
Nine patients underwent pelvic radiography (ante-
roposterior view) and four patients (44%) had sacroiliitis
(defined as unilateral changes grade 2). The mean GUESS
score of patients was 3.42, which was significantly higher
than that of the controls (1.71; p Z 0.03; Table 1). For
patients, the mean abnormality score for soft tissue usingUS was 3.21, and the bone score was 0.21. Soft tissue was
predominantly involved and the abnormal US findings are
illustrated in Fig. 1. In all, 42/140 (30%) and 21/140 (15%)
entheseal sites were abnormal in patients and controls,
respectively.
The most common abnormal enthesopathy was enthe-
seal thickness of the proximal patellar ligament, distal
proximal patellar ligament, and quadriceps tendon, fol-
lowed by bursitis of the quadriceps tendon enthesis.
Enthesophytes were not common, and bone erosion was not
observed (Tables 2 and 3). Twelve patients and seven
controls had 2 positive findings. The mean thickness of
the five entheseal sites is provided in Table 4. No significant
correlation was noted between the US score of enthesitis
and serum level of CRP (pZ 0.5). Only one patient received
corticosteroid therapy, and no patient used nonsteroidal
anti-inflammatory drugs (NSAIDs).
Discussion
None of our patients had peripheral joint pain or swelling,
physical examinations were unremarkable, and only three
patients had soreness in the lower back. Despite these
observations, positive US findings were noted in 13 of the 14
patients investigated and 10 of the 14 controls. If the cutoff
level was two positive findings, 12 of 14 patients and seven
of 14 controls had them.
Fig. 1 Representative US image of abnormal findings. (A) US shows a hypoechoic lesion under a quadriceps tendon, indicating
suprapatellar bursitis. (B) A hyperechoic spur, indicating a quadriceps enthesophyte. (C) A focal hypoechoic strip with thickness,
indicating proximal patellar entheseal thickening. PZ patella; PLZ patellar ligament; QZ quadriceps tendon; USZ ultrasound.
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sent study was higher than that reported previously [7,8].
Therefore, thickening of entheses may be an early sign of
joint involvement, which can lead to the formation of
enthesophytes, bone erosion, and, finally, bone destruction
[16e18]. Previously, evaluation of enthesitis has typically
been conducted with radiography or clinical assessments,
and positive findings have included detection of entheso-
phytes or more severe changes of enthesitis. Furthermore,
soft-tissue lesions can be underestimated by radiography or
clinical assessments. Clinical symptoms can be ignored by
patients and attending physicians. Thus, the prevalence of
enthesitis may be underestimated.
US has greater sensitivity than radiography and clinical
examination for enthesitis. An ultrasonographic survey can
detect joint involvement even in the early stages. We
applied PDUS to all participants, but significant findings
were not observed. US (especially PDUS) has been shown to
be a sensitive tool in the assessment of disease activity in
patients with rheumatoid arthritis, psoriatic arthritis, and
SpA [9,19]. The PDUS findings of our patients revealed no
active inflammation. This finding may explain why all our
patients were asymptomatic upon inclusion in this study.
Such patients can receive medications (e.g., prednisolone,
mesalamine, sulfasalazine, azathioprine, methotrexate,
and adalimumab) for IBD, and their symptoms of joint orTable 2 Distribution of morphostructural changes in soft
tissue in patients and controls.
Tendon enthesis Entheseal thickening Bursitis
Patients Controls Patients Controls
Quadriceps
enthesis
8 3 11 9
Proximal patellar
enthesis
12 9 0 0
Distal patellar
enthesis
9 2 0 0
Achilles
enthesis
1 0 3 0
Plantar
aponeurosis
enthesis
0 0 0 0
Total 30 14 14 9
Data are presented as n (number of abnormal entheseal sites).enthesis involvement may be partially treated or masked by
these medications. Thus, subclinical enthesitis in IBD pa-
tients has a higher percentage of enthesitis than that in the
normal population (30% vs. 15%), and this condition may be
underestimated by clinical examination and radiography
alone. Conversely, US would be a more sensitive tool for the
detection of entheseal abnormalities in IBD patients.
In the present study, the serum level of CRP did not show
correlation with the severity of enthesitis. The serum level
of CRP is a widely used marker for joint inflammation in
rheumatoid arthritis, psoriatic arthritis, and SpA, but CRP
levels are also elevated in IBD patients with highly active
disease. However, differentiating if the elevation in the
serum CRP level is caused by arthropathy or IBD is difficult.
The arthropathy of IBD may not be in proportion to the
disease activity of IBD according to a report by Orchard
et al [20]. Given that the physical examination of enthesitis
has low sensitivity and no specificity, US could be an
objective approach to the assessment of entheseal
abnormalities.
The first-line treatment of active enthesitis or arthritis is
NSAIDs. If a patient has IBD and enthesitis or sacroiliitis, he/
she can be classified as having SpA or axial SpA. The man-
agement of SpA includes NSAIDs, disease-modifying anti-
rheumatic drugs, or biologic agents. Patients can have more
treatment choices if they are classified as having SpA.
Conventional NSAIDs or cyclooxygenase (COX)-2-selective
inhibitors can relieve pain and inflammation, but should be
used with caution because of possible gastrointestinal
adverse effects. The risk of relapse of IBD due to NSAIDs use
is controversial [21,22]. COX-2-selective inhibitors have
been considered safe and beneficial for IBD treatmentTable 3 Distribution of the morphostructural changes of
the bone in the patients and controls.
Tendon enthesis Enthesophyte Bone erosion
Patients Controls Patients Controls
Quadriceps 1 0 0 0
Proximal patellar 0 0 0 0
Distal patellar 0 0 0 0
Achilles 2 0 0 0
Plantar aponeurosis 0 0 0 0
Total 3 0 0 0
Data are presented as n (number of abnormal entheseal sites).
Table 4 Mean values of entheseal thickness at five sites in
normal controls.
Tendon enthesis Thickness (mm)
Quadriceps 5.20
Proximal patellar 3.91
Distal patellar 3.39
Achilles 4.27
Plantar aponeurosis 2.45
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Early intervention with NSAIDs or COX-2-selective inhibitors
may halt the inflammation of joints and avoid further bony
destruction. The prevalence of radiological sacroiliitis in
patients with IBD has been found to be 10e32% [25e28].
The prevalence of sacroiliitis in our patients was much
higher (44%; 4/9). This high prevalence of sacroiliitis,
however, may be attributable to selection bias, small
sample size, or absence of a specific treatment design for
our patients.
Higher GUESS scores indicate greater involvement of
entheses. However, no cutoff level for the GUESS score has
been established to differentiate between patients and
normal controls. The Madrid Sonographic Enthesitis Index
has a recommended cutoff level for spondyloarthropathy
[29,30], but we did not use it because it has a relatively
complicated scoring method (score range, 0e136).
Two limitations of our study should be noted. The sam-
ple size was relatively small and the statistical power of
this number was not adequate. Hence, additional longitu-
dinal studies are needed to investigate whether these US
findings in IBD patients have a predictive value in indicating
future joint disorders.
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